Related Experiment Videos
Is familial hyperparathyroidism a unique disease?
M K Barry1, J A van Heerden, C S Grant
1Department of Gastroenterologic and General Surgery, Mayo Clinic, Rochester, MN 55905, USA.
Surgery
|January 14, 1998
Summary
Familial hyperparathyroidism, a rare aggressive condition, often presents in younger patients with kidney stones. Long-term monitoring is essential due to high recurrence rates.
Area of Science:
- Endocrinology
- Genetics
- Surgical Oncology
Background:
- Familial hyperparathyroidism (FHP) is a rare genetic disorder.
- FHP often exhibits more aggressive clinical behavior compared to sporadic forms.
- This study focuses on FHP without a history of multiple endocrine neoplasia.
Purpose of the Study:
- To characterize the clinical presentation and long-term outcomes of familial hyperparathyroidism.
- To evaluate the effectiveness of surgical management for FHP.
- To establish FHP as a distinct clinical entity.
Main Methods:
- Retrospective analysis of 30 patients with FHP from 1975 to 1995.
- Inclusion criteria: first-degree relative with hyperparathyroidism, no history of multiple endocrine neoplasia.
- Surgical interventions included primary and repeat explorations; follow-up ranged from 1 to 21 years.
Main Results:
- The study cohort included 19 women and 11 men, with a mean age of 39 years.
- Nephrolithiasis was present in 47% of patients; mean serum calcium was 11.6 mg/dl.
- Hypercalcemia persisted or recurred in 20% of patients post-surgery.
Conclusions:
- Familial hyperparathyroidism is a distinct entity with early onset and high rates of nephrolithiasis.
- Long-term follow-up is crucial due to high recurrence and persistent disease rates.
- Subtotal parathyroidectomy and transcervical thymectomy in experienced centers are recommended surgical approaches.